Literature DB >> 9378964

Signal transduction for melatonin in human lymphocytes: involvement of a pertussis toxin-sensitive G protein.

A García-Pergañeda1, D Pozo, J M Guerrero, J R Calvo.   

Abstract

We analyzed the melatonin signal transduction in human blood lymphocytes. High affinity melatonin receptors were identified by specific binding of 2-[125I]melatonin ([125I]MEL) to human lymphocyte membranes. Scatchard analysis of [125I]MEL binding revealed high affinity receptors, with a dissociation constant (Kd) of 0.45 nM and a binding capacity (Bmax) of 7.8 fmol/mg protein. Specific [125I]MEL binding was reduced markedly by GTP and its nonhydrolyzable analogues guanosine 5'-beta, gamma-imidotriphosphate (Gpp(NH)p) and guanosine 5'-O-(3-triphosphate) (GTP-gamma-S). Gpp(NH)p inhibited in a dose-dependent manner the [125I]MEL specifically bound to human lymphocyte membranes with a half-maximal inhibition (IC50) of 3.5 +/- 0.6 microM Gpp(NH)p. Treatment of human lymphocyte membranes with Gpp(NH)p increased the Kd value (Kd = 1.20 nM). Melatonin inhibited significantly and in a dose-dependent manner forskolin-stimulated cAMP production in intact human lymphocytes. Melatonin was able to stimulate diacylglycerol production in a dose-dependent manner in human lymphocyte membranes. Pertussis toxin treatment inhibited the specific [125I]MEL binding and blocked the ability of melatonin to both inhibit forskolin-stimulated cAMP production and stimulate diacylglycerol production. Pertussis toxin ADP-ribosylation and Western blot experiments demonstrated the protein expression of alpha i1/2, alpha i3/0, and beta gamma complexes of G proteins in human lymphocyte membranes. The results strongly suggest a pertussis toxin-sensitive melatonin signal transduction pathway in human lymphocytes that involves the inhibition of adenylyl cyclase and the stimulation of phospholipase C.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9378964

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  11 in total

Review 1.  A review of the multiple actions of melatonin on the immune system.

Authors:  Antonio Carrillo-Vico; Juan M Guerrero; Patricia J Lardone; Russel J Reiter
Journal:  Endocrine       Date:  2005-07       Impact factor: 3.633

2.  Melatonin enhances Th2 cell mediated immune responses: lack of sensitivity to reversal by naltrexone or benzodiazepine receptor antagonists.

Authors:  V Raghavendra; V Singh; S K Kulkarni; J N Agrewala
Journal:  Mol Cell Biochem       Date:  2001-05       Impact factor: 3.396

Review 3.  Breast Milk and the Importance of Chrononutrition.

Authors:  Mario Daniel Caba-Flores; Angel Ramos-Ligonio; Alberto Camacho-Morales; Carmen Martínez-Valenzuela; Rubí Viveros-Contreras; Mario Caba
Journal:  Front Nutr       Date:  2022-05-12

Review 4.  Extrapineal melatonin: sources, regulation, and potential functions.

Authors:  Darío Acuña-Castroviejo; Germaine Escames; Carmen Venegas; María E Díaz-Casado; Elena Lima-Cabello; Luis C López; Sergio Rosales-Corral; Dun-Xian Tan; Russel J Reiter
Journal:  Cell Mol Life Sci       Date:  2014-02-20       Impact factor: 9.261

5.  Melatonin, immune function and aging.

Authors:  V Srinivasan; G J M Maestroni; D P Cardinali; A I Esquifino; S R Pandi Perumal; S C Miller
Journal:  Immun Ageing       Date:  2005-11-29       Impact factor: 6.400

Review 6.  Dietary Sources and Bioactivities of Melatonin.

Authors:  Xiao Meng; Ya Li; Sha Li; Yue Zhou; Ren-You Gan; Dong-Ping Xu; Hua-Bin Li
Journal:  Nutrients       Date:  2017-04-07       Impact factor: 5.717

Review 7.  Membrane Melatonin Receptors Activated Cell Signaling in Physiology and Disease.

Authors:  Georgi Nikolaev; Ralitsa Robeva; Rossitza Konakchieva
Journal:  Int J Mol Sci       Date:  2021-12-31       Impact factor: 5.923

8.  The effect of preoperative melatonin on nuclear erythroid 2-related factor 2 activation in patients undergoing coronary artery bypass grafting surgery.

Authors:  Shaghayegh Haghjooy Javanmard; Amin Ziaei; Saeid Ziaei; Ehsan Ziaei; Mohsen Mirmohammad-Sadeghi
Journal:  Oxid Med Cell Longev       Date:  2013-04-08       Impact factor: 6.543

9.  Melatonin anticancer effects: review.

Authors:  Giuseppe Di Bella; Fabrizio Mascia; Luciano Gualano; Luigi Di Bella
Journal:  Int J Mol Sci       Date:  2013-01-24       Impact factor: 5.923

Review 10.  Melatonin and viral infections.

Authors:  Ernesto Bonilla; Nereida Valero; Leonor Chacín-Bonilla; Shirley Medina-Leendertz
Journal:  J Pineal Res       Date:  2004-03       Impact factor: 13.007

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.